262 related articles for article (PubMed ID: 24980176)
1. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
Kellner CH; Greenberg RM; Ahle GM; Liebman LS
Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
[No Abstract] [Full Text] [Related]
2. A word to the wise about ketamine.
Schatzberg AF
Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
[No Abstract] [Full Text] [Related]
3. Ketamine for treatment-resistant depression: ready or not for clinical use?
Rush AJ
Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
[No Abstract] [Full Text] [Related]
4. Ketamine as an alternative treatment for treatment-resistant depression.
Dowben JS; Grant JS; Keltner NL
Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
[No Abstract] [Full Text] [Related]
5. Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.
Blier P
Biol Psychiatry; 2013 Aug; 74(4):238-9. PubMed ID: 23885752
[No Abstract] [Full Text] [Related]
6. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
[No Abstract] [Full Text] [Related]
7. Ketamine for Treatment-Resistant Depression: a New Advocate.
Pérez-Esparza R
Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
[TBL] [Abstract][Full Text] [Related]
9. [Ketamine--a new treatment option for therapy-resistant depression].
Köhler S; Betzler F
Fortschr Neurol Psychiatr; 2015 Feb; 83(2):91-7. PubMed ID: 25723773
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.
Campion P
Psychiatry Res; 2015 Jan; 225(1-2):216. PubMed ID: 25511507
[No Abstract] [Full Text] [Related]
11. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
Abdallah CG; Sanacora G; Duman RS; Krystal JH
Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
[TBL] [Abstract][Full Text] [Related]
12. Speed of response to electroconvulsive therapy compared with ketamine.
Kellner CH; ; Lisanby SH; Weiner R; Prudic J; Rudorfer MV; Young RC; Petrides G; McCall WV; Husain M; Greenberg RM; Knapp RG
Psychiatry Res; 2015 Jan; 225(1-2):215. PubMed ID: 25511506
[No Abstract] [Full Text] [Related]
13. Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage.
Scheele D; Zimbal S; Feinstein JS; Delis A; Neumann C; Mielacher C; Philipsen A; Hurlemann R
Am J Psychiatry; 2019 Dec; 176(12):982-986. PubMed ID: 31787017
[No Abstract] [Full Text] [Related]
14. Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report.
Gálvez V; O'Keefe E; Cotiga L; Leyden J; Harper S; Glue P; Mitchell PB; Somogyi AA; DeLory A; Loo CK
Biol Psychiatry; 2014 Aug; 76(3):e1-2. PubMed ID: 24507509
[No Abstract] [Full Text] [Related]
15. Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.
Zhang MW; Ho R
Am J Psychiatry; 2016 Apr; 173(4):431. PubMed ID: 27035535
[No Abstract] [Full Text] [Related]
16. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
McIntyre RS; Rosenblat JD; Nemeroff CB; Sanacora G; Murrough JW; Berk M; Brietzke E; Dodd S; Gorwood P; Ho R; Iosifescu DV; Lopez Jaramillo C; Kasper S; Kratiuk K; Lee JG; Lee Y; Lui LMW; Mansur RB; Papakostas GI; Subramaniapillai M; Thase M; Vieta E; Young AH; Zarate CA; Stahl S
Am J Psychiatry; 2021 May; 178(5):383-399. PubMed ID: 33726522
[TBL] [Abstract][Full Text] [Related]
17. Response to Zhang and Ho: Addressing Ketamine's Use in Depression.
Newport DJ; Nemeroff CB
Am J Psychiatry; 2016 Apr; 173(4):431-2. PubMed ID: 27035536
[No Abstract] [Full Text] [Related]
18. NMDA antagonist treatment of depression.
Williams NR; Schatzberg AF
Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
[TBL] [Abstract][Full Text] [Related]
19. Disentangling the association of depression on the anti-fatigue effects of ketamine.
Saligan LN; Farmer C; Ballard ED; Kadriu B; Zarate CA
J Affect Disord; 2019 Feb; 244():42-45. PubMed ID: 30312839
[TBL] [Abstract][Full Text] [Related]
20. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
